Thus, deficiencies in L-carnitine or its transporter CAC have particularly adverse effects on cardiomyocytes, resulting in cardiomyopathy, cardiac arrhythmia, cardiac insufficiency, and heart failure [4]
Compounded medications may be prepared by licensed pharmacies under provider supervision, but compounded products are not FDA-approved as finished drugs
Archived from the original on 27 April 2017
Drug-drug interactions are minimal given predominant non-renal, non-hepatic elimination pathways, though delayed gastric emptying may affect absorption of oral medications with narrow therapeutic windows
[2] Peptide Stability and Structure Studies: Its defined pentapeptide structure supports investigation into structureactivity relationships and peptide-receptor binding dynamics
NSL literature pointer PMID 26320283 L-Carnitine laboratory index [PMID: 26320283] National Science Labs indexing note for PMID 26320283: review the PubMed methods, models, and limitations before citing